Press Resease

Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 30-Jul-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-4511 Status : Published

Global allergy immunotherapy market expected to generate around USD 3.76 billion by 2025, at a CAGR of around 10.5% between 2019 and 2025. Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies.

Description

The report covers a forecast and an analysis of the allergy immunotherapy market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the allergy immunotherapy market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the allergy immunotherapy market on a global level.

In order to give the users of this report a comprehensive view of the allergy immunotherapy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the allergy immunotherapy market by segmenting it on the basis of treatment type, allergy type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players involved in the global allergy immunotherapy market are Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis.

This report segments the global allergy immunotherapy market as follows:

Global Allergy Immunotherapy Market: Treatment Type Analysis

  • SCIT
  • SLIT

Global Allergy Immunotherapy Market: Allergy Type Analysis

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Global Allergy Immunotherapy Market: Distribution Channel Analysis

  • Hospital Pharmacy
  • Retail Pharmacy and Drug Stores
  • Online Pharmacy

Global Allergy Immunotherapy Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global allergy immunotherapy market, 2016-2025 (USD Billion)
    • 2.2. Global allergy immunotherapy market: Snapshot
  •  
  • Chapter 3. Allergy Immunotherapy Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global allergy immunotherapy market drivers: Impact analysis
      • 3.2.2. Rising prevalence of allergic diseases
      • 3.2.3. Increasing awareness about allergy treatment
      • 3.2.4. High clinical R&D budget by governments and non-profit organizations
    • 3.3. Market Restraints
      • 3.3.1. Global allergy immunotherapy market restraints: Impact analysis
      • 3.3.2. The dearth of Trained Professionals
      • 3.3.3. High Cost of Procedure
    • 3.4. Opportunities
      • 3.4.1. Promising product pipeline
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by treatment type
      • 3.6.2. Market attractiveness analysis, by allergy type
      • 3.6.3. Market attractiveness analysis, by distribution channel
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Allergy Immunotherapy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global allergy immunotherapy market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Allergy Immunotherapy Market - Treatment Type Analysis
    • 5.1. Global allergy immunotherapy market: Treatment Type overview
      • 5.1.1. Global allergy immunotherapy market revenue share, by treatment type, 2018 and 2025
    • 5.2. SCIT
      • 5.2.1. Global allergy immunotherapy market for SCIT, 2016-2025 (USD Billion)
    • 5.3. SLIT
      • 5.3.1. Global allergy immunotherapy market for SLIT, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Allergy Immunotherapy Market - Allergy Type Analysis
    • 6.1. Global allergy immunotherapy market: Allergy Type overview
      • 6.1.1. Global allergy immunotherapy market revenue share, by allergy type, 2018 and 2025
    • 6.2. Allergic Rhinitis
      • 6.2.1. Global allergy immunotherapy market for allergic rhinitis, 2016-2025 (USD Billion)
    • 6.3. Asthma
      • 6.3.1. Global allergy immunotherapy market for asthma, 2016-2025 (USD Billion)
    • 6.4. Food Allergy
      • 6.4.1. Global allergy immunotherapy market for food allergy, 2016-2025 (USD Billion)
    • 6.5. Venom Allergy
      • 6.5.1. Global allergy immunotherapy market for venom allergy, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global allergy immunotherapy market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Allergy Immunotherapy Market - Distribution Channel Analysis
  • 7.1. Global allergy immunotherapy market: Distribution Channel overview
    • 7.1.1. Global allergy immunotherapy market revenue share, by distribution channel, 2018 and 2025
  • 7.2. Retail Pharmacy and Drug Stores
    • 7.2.1. Global allergy immunotherapy market for retail pharmacy and drug stores, 2016-2025 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global allergy immunotherapy market for hospital pharmacy, 2016-2025 (USD Billion)
  • 7.4. Online Pharmacy
    • 7.4.1. Global allergy immunotherapy market for online pharmacy, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Allergy Immunotherapy Market - Regional Analysis
    • 8.1. Global allergy immunotherapy market: Regional overview
      • 8.1.1. Global allergy immunotherapy market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.2.2. North America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.2.3. North America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.2.4. North America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.2.5.2. The U.S. allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.2.5.3. The U.S. allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.2.6.2. Canada allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.2.6.3. Canada allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.3.2. Europe allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.3.3. Europe allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.3.4. Europe allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.5.2. UK allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.5.3. UK allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.6.2. Germany allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.6.3. Germany allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.7.2. France allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.7.3. France allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.8.2. Rest of Europe allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.8.3. Rest of Europe allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.4.4. Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.5.2. China allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.5.3. China allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.6.2. Japan allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.6.3. Japan allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.7.2. India allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.7.3. India allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.5.2. Latin America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.5.3. Latin America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.5.4. Latin America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.5.5.2. Brazil allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.5.5.3. Brazil allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.5.6.2. Rest of Latin America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.5.6.3. Rest of Latin America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.6.4. The Middle East and Africa allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Stallergenes Greer
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Aimmune Therapeutics
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. ALK-Abello
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Allergy Therapeutics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Merck
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. HAL Allergy
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. DBV Technologies
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Circassia
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Biomay
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Anergis
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Methodology

Free Analysis

Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies. The main aim of immunotherapy is to desensitize one’s immune system against a particular allergen, which triggers the allergy.

According to the American College of Allergy, Asthma, and Immunology, allergies are the sixth leading cause of chronic illness in North America. According to the CDC, above 50 million Americans suffer from different types of allergies annually. The increasing number of patients suffering from different types of allergies, rising government investments is fueling the global allergy immunotherapy market. Additionally, the growing R&D activities by companies for developing new technologies, rising awareness about the efficiency of allergy immunotherapies, and increasing population that is prone to allergies due to various diseases are some other factors fueling the allergy immunotherapy market globally. However, the lack of skilled professionals and high technological cost may hamper this market’s development.

The allergy immunotherapy market is fragmented on the basis of allergy type, treatment type, and distribution channel. Based on treatment type, the market includes subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). The SCIT segment is anticipated to dominate the market in the years ahead, owing to its effectiveness to treat various allergies like asthma. By allergy type, the market for allergy immunotherapy is divided into asthma, venom allergy, food allergy, allergic rhinitis, and others. Allergic rhinitis is expected to dominate the market for allergy immunotherapy. The asthma segment is expected to show a higher growth rate in the future, owing to the growing asthma prevalence worldwide. The distribution channel segment of the allergy immunotherapy market comprises retail pharmacy and drug stores, online pharmacy, and hospital pharmacy.

Europe is projected to dominate the allergy immunotherapy market, owing to the early introduction of immunotherapy treatments, an increasing geriatric population that is prone to different allergies, and rising number of supportive reimbursement policies by the government. The Asia Pacific allergy immunotherapy market is anticipated to show the highest growth rate in the upcoming years, owing to the rising investments and funding by government for R&D, increasing number of people suffering from allergies, and growing awareness about the benefits of allergy immunotherapy to treat various allergies.

Some major players involved in the global allergy immunotherapy market are Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com